SCHEMBL6351098

SCHEMBL6351098

ClC1=NN(Cl)NC(C2CC2)=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6033866 0.67 — —
SCHEMBL5488803 0.63 — —
SCHEMBL14473180 0.52 — —
SCHEMBL9625913 0.51 — —
SCHEMBL4080848 0.47 — —
SCHEMBL7851839 0.47 — —
SCHEMBL1083341 0.47 — —
SCHEMBL904190 0.46 KDM4E (0.37) —
SCHEMBL1089282 0.45 — —
SCHEMBL1787799 0.44 PDE10A (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6894047-B2 Triazine compounds useful as sorbitol dehydrogenase inhibitors PFIZER INC. (US) 2005-05-17 — — US disclosed
US-20030004166-A1 Novel triazine compounds useful as sorbitol dehydrogenase inhibitors PFIZER INC. 2003-01-02 — — US disclosed
EP-1247809-A2 Triazine compounds useful as sorbitol dehydrogenase inhibitors Pfizer Products Inc. (US) 2002-10-09 — — EP disclosed
Send feedback